SBRT2015

National Cancer Database (1998-2010) Stage I NSCLC ( 5,944 SBRT, 13,429 CFRT)

•

All patients

No chemotherapy

1.0

1.0

Median OS 29.8 vs. 26.2 months p<0.001

Median OS 32.3 vs. 25.6 months p<0.001

0.75

0.75

0.50

0.50

Conventional SBRT

Conventional SBRT

Survival

Survival

0.25

0.25

0.0 0 12 24 36 48 60 72 84 96 108

0.0 0 12 24 36 48 60 72 84 96 108

Months

Months

– SBRT improved OS compared with CFRT regardless of chemotherapy use in this population-based analysis of clinical stage I NSCLC

Robinson C. proc ASCO 2015 abstr 7513